Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220798970> ?p ?o ?g. }
- W4220798970 endingPage "2014" @default.
- W4220798970 startingPage "2000" @default.
- W4220798970 abstract "Genomic tumour profiling informs targeted treatment options. Entrectinib is a tyrosine kinase inhibitor with efficacy in NTRK fusion-positive (-fp) solid tumours and ROS1-fp non-small cell lung cancer. FoundationOne® Liquid CDx (F1L CDx), a non-invasive in vitro next-generation sequencing (NGS)-based diagnostic, detects genomic alterations in plasma circulating tumour DNA (ctDNA). We evaluated the clinical validity of F1L CDx as an aid in identifying patients with NTRK-fp or ROS1-fp tumours and assessed the genomic landscape pre- and post-entrectinib treatment. Among evaluable pre-treatment clinical samples (N = 85), positive percentage agreements between F1L CDx and clinical trial assays (CTAs) were 47.4% (NTRK fusions) and 64.5% (ROS1 fusions); positive predictive value was 100% for both. The objective response rate for CTA+ F1L CDx+ patients was 72.2% in both cohorts. The median duration of response significantly differed between F1L CDx+ and F1L CDx- samples in ROS1-fp (5.6 vs. 17.3 months) but not NTRK-fp (9.2 vs. 12.9 months) patients. Fifteen acquired resistance mutations were detected. We conclude that F1L CDx is a clinically valid complement to tissue-based testing to identify patients who may benefit from entrectinib and those with acquired resistance mutations associated with disease progression." @default.
- W4220798970 created "2022-04-03" @default.
- W4220798970 creator A5021287587 @default.
- W4220798970 creator A5030691366 @default.
- W4220798970 creator A5033872709 @default.
- W4220798970 creator A5034705456 @default.
- W4220798970 creator A5046006373 @default.
- W4220798970 creator A5046660353 @default.
- W4220798970 creator A5049476184 @default.
- W4220798970 creator A5054931755 @default.
- W4220798970 creator A5057478022 @default.
- W4220798970 creator A5063199354 @default.
- W4220798970 creator A5070120529 @default.
- W4220798970 creator A5071168587 @default.
- W4220798970 creator A5071439910 @default.
- W4220798970 creator A5078202936 @default.
- W4220798970 creator A5087836238 @default.
- W4220798970 creator A5089925113 @default.
- W4220798970 date "2022-04-22" @default.
- W4220798970 modified "2023-09-25" @default.
- W4220798970 title "Pre‐ and post‐treatment blood‐based genomic landscape of patients with <i>ROS1</i> or <i>NTRK</i> fusion‐positive solid tumours treated with entrectinib" @default.
- W4220798970 cites W1902628090 @default.
- W4220798970 cites W2041266959 @default.
- W4220798970 cites W2098742726 @default.
- W4220798970 cites W2103447891 @default.
- W4220798970 cites W2105660133 @default.
- W4220798970 cites W2109269285 @default.
- W4220798970 cites W2119048498 @default.
- W4220798970 cites W2150575159 @default.
- W4220798970 cites W2194998434 @default.
- W4220798970 cites W2304533799 @default.
- W4220798970 cites W2507915407 @default.
- W4220798970 cites W2599294066 @default.
- W4220798970 cites W2792093743 @default.
- W4220798970 cites W2797513078 @default.
- W4220798970 cites W2806841724 @default.
- W4220798970 cites W2807519281 @default.
- W4220798970 cites W2889170871 @default.
- W4220798970 cites W2899311685 @default.
- W4220798970 cites W2900674461 @default.
- W4220798970 cites W2911769095 @default.
- W4220798970 cites W2930374839 @default.
- W4220798970 cites W2946961640 @default.
- W4220798970 cites W2968529981 @default.
- W4220798970 cites W2978282055 @default.
- W4220798970 cites W2980774213 @default.
- W4220798970 cites W2982291252 @default.
- W4220798970 cites W2988707913 @default.
- W4220798970 cites W2990091274 @default.
- W4220798970 cites W2995220921 @default.
- W4220798970 cites W2996493142 @default.
- W4220798970 cites W2996574710 @default.
- W4220798970 cites W3000565767 @default.
- W4220798970 cites W3012074589 @default.
- W4220798970 cites W3020913855 @default.
- W4220798970 cites W3031159445 @default.
- W4220798970 cites W3047057449 @default.
- W4220798970 cites W3088519161 @default.
- W4220798970 cites W3102224823 @default.
- W4220798970 cites W3127113113 @default.
- W4220798970 cites W3162309098 @default.
- W4220798970 cites W3198098407 @default.
- W4220798970 doi "https://doi.org/10.1002/1878-0261.13214" @default.
- W4220798970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35338679" @default.
- W4220798970 hasPublicationYear "2022" @default.
- W4220798970 type Work @default.
- W4220798970 citedByCount "5" @default.
- W4220798970 countsByYear W42207989702022 @default.
- W4220798970 countsByYear W42207989702023 @default.
- W4220798970 crossrefType "journal-article" @default.
- W4220798970 hasAuthorship W4220798970A5021287587 @default.
- W4220798970 hasAuthorship W4220798970A5030691366 @default.
- W4220798970 hasAuthorship W4220798970A5033872709 @default.
- W4220798970 hasAuthorship W4220798970A5034705456 @default.
- W4220798970 hasAuthorship W4220798970A5046006373 @default.
- W4220798970 hasAuthorship W4220798970A5046660353 @default.
- W4220798970 hasAuthorship W4220798970A5049476184 @default.
- W4220798970 hasAuthorship W4220798970A5054931755 @default.
- W4220798970 hasAuthorship W4220798970A5057478022 @default.
- W4220798970 hasAuthorship W4220798970A5063199354 @default.
- W4220798970 hasAuthorship W4220798970A5070120529 @default.
- W4220798970 hasAuthorship W4220798970A5071168587 @default.
- W4220798970 hasAuthorship W4220798970A5071439910 @default.
- W4220798970 hasAuthorship W4220798970A5078202936 @default.
- W4220798970 hasAuthorship W4220798970A5087836238 @default.
- W4220798970 hasAuthorship W4220798970A5089925113 @default.
- W4220798970 hasBestOaLocation W42207989701 @default.
- W4220798970 hasConcept C121608353 @default.
- W4220798970 hasConcept C126322002 @default.
- W4220798970 hasConcept C143998085 @default.
- W4220798970 hasConcept C2775999482 @default.
- W4220798970 hasConcept C2776256026 @default.
- W4220798970 hasConcept C2781182431 @default.
- W4220798970 hasConcept C502942594 @default.
- W4220798970 hasConcept C535046627 @default.
- W4220798970 hasConcept C71924100 @default.
- W4220798970 hasConceptScore W4220798970C121608353 @default.
- W4220798970 hasConceptScore W4220798970C126322002 @default.